search
Back to results

Respiration Gated Laser Guided CT Lung Nodule Biopsy (GENCTBIOPSY)

Primary Purpose

Lung Cancer

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Bellows-based breath hold device
Sponsored by
University Hospital, Gentofte, Copenhagen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lung Cancer focused on measuring CT, lung nodule biopsy, Respiration Gated, Lung Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients with indeterminate lung nodules referred from the department of pulmonary medicine at Gentofte Hospital, Denmark for a CT guided biopsy are considered for inclusion in this study. The biopsy was preformed as part of regular clinical work up of the patient at the department of Radiology Gentofte Hospital, Denmark. Both men and women were included and no age restrictions were applied.

Exclusion Criteria:

Excluded from biopsy were those with poor pulmonary function test with a forced expired volume in the first second (FEV1) < 0.5 L, INR>1.2, blood cloth level under 200* and ECG with sign of ischemic heart disease. The trial is planned to begin 1.March 2010 and run for 2 years ending at 29 February 2012. During this time approx. 400 participants planned for biopsy are accepted to be included in the trial.

Sites / Locations

  • Gentofte University Hospital, Department of RadiologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Bellows-based breath hold biopsy

No Bellows-based breath hold.

Arm Description

CT guided biopsy is preformed with the use a bellows-based breath

CT guided biopsy is preformed without the use a bellows-based breath

Outcomes

Primary Outcome Measures

Accuracy of respiration gated laser guided CT lung nodule biopsy
The primary outcome of this study is to investigate the accuracy of respiration gated laser guided CT lung nodule biopsy through a prospective randomized trial using a bellows-based breath hold monitoring system.

Secondary Outcome Measures

Full Information

First Posted
November 8, 2010
Last Updated
November 8, 2010
Sponsor
University Hospital, Gentofte, Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT01236937
Brief Title
Respiration Gated Laser Guided CT Lung Nodule Biopsy
Acronym
GENCTBIOPSY
Official Title
Respiration Gated Laser Guided CT Lung Nodule Biopsy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2010
Overall Recruitment Status
Unknown status
Study Start Date
March 2010 (undefined)
Primary Completion Date
March 2012 (Anticipated)
Study Completion Date
July 2012 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Gentofte, Copenhagen

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary outcome of this study is to investigate the accuracy of respiration gated laser guided CT lung nodule biopsy through a prospective randomized trial using a bellows-based breath hold monitoring system. Secondary outcome is the rate of complications using laser guided CT biopsy in general and with bellows-based breath hold monitoring system. The study has approval from the The Danish National Committee on Biomedical Research Ethics (ref no: H-4-2010-fsp 1).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer
Keywords
CT, lung nodule biopsy, Respiration Gated, Lung Cancer

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Bellows-based breath hold biopsy
Arm Type
Active Comparator
Arm Description
CT guided biopsy is preformed with the use a bellows-based breath
Arm Title
No Bellows-based breath hold.
Arm Type
No Intervention
Arm Description
CT guided biopsy is preformed without the use a bellows-based breath
Intervention Type
Device
Intervention Name(s)
Bellows-based breath hold device
Intervention Description
Bellows-Based breath hold monitoring system: The bellows-based breath hold system (IBC, Mayo Clinic Medical Devices, USA) contains of 2 elements; one belt which is strapped around the thorax of the patient and a voltage controlled light unit with 8 lights. Belt stretch from respiratory motion is converted into voltage readings and displayed on the light unit giving biofeedback as different lights are activated depending on the dept of the respiration. Patients are instructed to keep respiration constant at a certain dept during the second the guide needle is inserted by controlling their breath with the help of the light unit. The patient is given a brief introduction to the system as to how the lights get turned on and off due to respiration motion before the biopsy is preformed.
Primary Outcome Measure Information:
Title
Accuracy of respiration gated laser guided CT lung nodule biopsy
Description
The primary outcome of this study is to investigate the accuracy of respiration gated laser guided CT lung nodule biopsy through a prospective randomized trial using a bellows-based breath hold monitoring system.
Time Frame
After 2 years

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with indeterminate lung nodules referred from the department of pulmonary medicine at Gentofte Hospital, Denmark for a CT guided biopsy are considered for inclusion in this study. The biopsy was preformed as part of regular clinical work up of the patient at the department of Radiology Gentofte Hospital, Denmark. Both men and women were included and no age restrictions were applied. Exclusion Criteria: Excluded from biopsy were those with poor pulmonary function test with a forced expired volume in the first second (FEV1) < 0.5 L, INR>1.2, blood cloth level under 200* and ECG with sign of ischemic heart disease. The trial is planned to begin 1.March 2010 and run for 2 years ending at 29 February 2012. During this time approx. 400 participants planned for biopsy are accepted to be included in the trial.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Haseem Ashraf, MD, PhD
Email
haseem.ashraf@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Haseem Ashraf, MD, PhD
Organizational Affiliation
Gentofte University Hospital, Department of Radiology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Paul Clementsen, MD, PhD
Organizational Affiliation
Gentofte University Hospital, Department of Pulmonology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Annete Nørgaard, MD, PhD
Organizational Affiliation
Gentofte University Hospital, Department of Pulmonology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Peter S. Myschetzky, MD
Organizational Affiliation
Gentofte University Hospital, Department of Radiology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Asger Dirksen, MD, PhD
Organizational Affiliation
Gentofte University Hospital, Department of Pulmonology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Zaigham Saghir, MD
Organizational Affiliation
Gentofte University Hospital, Department of Pulmonology
Official's Role
Study Chair
Facility Information:
Facility Name
Gentofte University Hospital, Department of Radiology
City
Hellerup
State/Province
Copenhagen
ZIP/Postal Code
2900
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Haseem Ashraf, MD, PhD
Email
haseem.ashraf@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Respiration Gated Laser Guided CT Lung Nodule Biopsy

We'll reach out to this number within 24 hrs